US President Donald Trump on Thursday signed an Executive Order to increase American production of essential medical supplies and cut down the nation’s reliance on foreign producers of medicines.
Peter Navarro, director of the White House's Office of Trade and Manufacturing Policy, said on a press call Thursday that the COVID-19 pandemic had made clear the need for the executive order, another in a long line of "Buy American" and "Hire American” directives introduced during the Trump administration.
Under the order, the Commissioner of Food and Drugs is directed to create a list of medicines, medical countermeasures, and critical inputs that are essential for public health in America.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze